BENDAMUSTINE ACCORD 25 mg/ml, concentrate for solution for infusion 5 bottles of 4 ml
Active ingredients: Bendamustine hydrochloride, Bendamustine hydrochloride monohydrate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion5 bottles of 4 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BENDAMUSTINE ACCORD 25 mg/mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre brun de 4 ml
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Mar 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63551287CIP75508807CIP133400955088073Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE BENDAMUSTINE MONOHYDRATÉsolution | — | SA |
| CHLORHYDRATE DE BENDAMUSTINEsolution | 25 mg · 1 mL de solution à diluer | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.